Pharmaceutical Marketing Strategies

Exploring Business Development Strategies for Pharma Startups

October 25, 2023 - Pharmaceutical startups face significant challenges in the ever-evolving healthcare industry. A 2020 Drug Discovery Today article emphasized that these challenges often result from unclear business models, the absence of a go-to-market strategy, or an inadequately defined value proposition. Moreover, the COVID-19 pandemic has compounded these hurdles, making it essential for startups to...

Read More


More Articles

How Can Pharmaceutical Companies Meet Drug Launch Expectations

by Veronica Salib

Earlier this month, Deloitte published a report evaluating why so many drug launches failed to meet their expectations. According to data analyzed by the Deloitte Center for Health Solutions through the Life Sciences and Healthcare...

Can Pharmaceutical Companies Ethically Sponsor Medical Education?

by Veronica Salib

The pharmaceutical industry plays a pivotal role in healthcare, driving innovation and providing new tools to optimize patient care and management. Despite the many benefits offered by pharmaceutical companies and manufacturers, there is...

FDA Issues Warning Letters for Marketing Unapproved Ophthalmic Drugs

by Veronica Salib

On September 12, 2023, the United States Food and Drug Administration (FDA) issued warning letters to eight companies, including Boiron Inc, CVS Health, DR Vitamin Solutions, Natural Ophthalmics Inc,...

Dissecting Ethical Principles in the Pharmaceutical Industry

by Veronica Salib

According to the Seven Pillars Institute for Global Finance and Ethics, various ethical issues are pressing the pharmaceutical industry and its stakeholders, including researchers, pharmacists, pharmaceutical companies, other healthcare...

FDA Issues Draft Guidance on Accelerated Approval for Oncology Drugs

by Veronica Salib

On March 24, 2023, the FDA issued a draft guidance on the clinical trial considerations for the accelerated approval of oncology drugs. The proposed recommendations include guidelines to fortify and...

Meteoric Rise of Weight-Loss Drug Wegovy Brings Pushback to Novo Nordisk

by Hayden Schmidt

In June of 2021, the FDA approved Novo Nordisk’s Wegovy to aid in weight management in overweight adults with weight-related chronic conditions like high blood pressure, type 2 diabetes, or high...

Understanding Differences between Generic, Brand Name, Biosimilars

by Veronica Salib

Every day patients, payers, and providers must navigate the pharmaceutical industry to obtain and deliver treatment. Unfortunately, the industry is full of language and nuances that make this process unnecessarily difficult. When providers...

How A Prescription Drug Becomes Available Over the Counter

by Veronica Salib

The FDA approval process is complex and involves multiple steps. Understanding how a prescription drug becomes available over the counter (OTC) is essential for healthcare professionals, members of the pharmaceutical industry, and...

DTC Pharmaceutical Marketing Linked $324B in Medicare Drug Spending

by Samantha McGrail

Medicare drug spending reached $560 billion from 2016 through 2018, with pharmaceutical marketing accounting for nearly $324 billion in overall spending, according to a GAO study. Of the 553...

Combating Antimicrobial Resistance Through Global Market Reform

by Samantha McGrail

A Pioneer Institute report found that market reforms using “push” and “pull” funding will help to combat the global antimicrobial resistance crisis.  The CDC considers...

Gene Therapy, Regenerative Medicine Markets Booming Worldwide

by Samantha McGrail

Globally, companies manufacturing gene therapy, cell therapy, and other regenerative medicines raised nearly $10 billion in 2019, the second-highest year on record, according to a recent analysis from...

FDA Boosts Affordable Access to Insulin and Biological Products

by Samantha McGrail

The Food and Drug Administration (FDA) recently published a final rule and additional resources to provide useful information to healthcare providers to ensure smooth regulatory transition of insulin...

Congress’ Think Tank Digs Into Drug Patenting Practices

by Ana Mulero

A new Congressional Research Service report on Wednesday delved into the deluge of proposals that have been set forth to address drug pricing and drug patenting practices. The report is a high-level...

Study: FDA Should Simplify Drug Approval Programs

by Ana Mulero

A new study published Tuesday in JAMA suggests that the evolution of drugs and biologics’ regulatory approval programs at the US Food and Drug Administration has resulted in a system that...

Pharmaceutical Marketing Strategies Targeting Medication Adherence

by Sara Heath

Medication adherence is essential to effective chronic disease management. But as healthcare industry experts see adherence rates flounder, it must look to targeted pharmaceutical marketing...

Recent Articles